Phase
Condition
N/ATreatment
N/AClinical Study ID
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria for the group "exercise-induced bronchospasm":
The subject must have a diagnosis of asthma according to 2010 Canadian ThoracicSociety consensus criteria since more then one year.
The subject should have an average expiratory volume per second (FEV1) ≥ 80% of thepredicted value (post bronchodilatation) at the time of the initial visit.
The subject must have had a positive methacholine test at the first visit of the studydemonstrating the presence of bronchial hyperreactivity.
The subject must have asthma control as defined by 2010 Canadian Thoracic Societyconsensus, with the obvious exception of limitations related to physical activity.
The subject must have at the questionnaire significant symptoms of exercise-inducedbronchospasm for more than 6 months. Inclusion Criteria for the group "healthy":
The subject should not have a positive history of eczema, urticaria or allergicrhinitis for life.
The subject should have a FEV1 ≥ 80% of the predicted value and an FEV1 / FVC (Forcedvital capacity) ratio of ≥70% at the time of the initial visit.
The subject should have a negative methacholine test at the first visit of the study.
The subject should not exhibit symptoms considered clinically compatible with EIBdiagnosis.
Exclusion
Exclusion Criteria:
Pregnant or breast-feeding women.
The subject should not suffer from clinically significant concomitant diseases thatmay compromise the course of the study.
The subject should not have taken per os or intravenously steroids in the 8 weeksprior to the study.
The subject should not have experienced significant symptoms of respiratory tractinfection (viral or bacterial) in the 8 weeks prior to the study.
The subject must not have participated in another study during the month preceding thedate of enrollment of this study.
The subject should not have smoked within the last 6 months. Exclusion criteria during the study:
The subject doesn't show up for all 3 visits or doesn't complete all required exams.
The subject develops a respiratory tract infection, an acute exacerbation of hisasthma or any other conditions that compromise his participation in the requiredexaminations.
The subject has a pre-test FEV1 of less than 80%.
Study Design
Connect with a study center
Université de Sherbrooke
Sherbrooke, Quebec J1G2E8
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.